Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bonollo, specifically Distillerie Bonollo Umberto, is an Italian industrial group that leverages advanced distillation and extraction technologies to serve the pharmaceutical, nutraceutical, and cosmetic sectors. While historically rooted in the production of grappa, the company has developed a sophisticated circular economy platform to recover high-value bioactive compounds from grape pomace. Their product portfolio includes natural tartaric acid, polyphenols such as resveratrol, and high-purity ethanol used as a pharmaceutical excipient. Bonollo's manufacturing processes emphasize sustainability and comply with rigorous quality standards for health-related applications. The company operates as a key supplier of natural ingredients for health supplements and medical formulations globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bonollo.